Antibody-dependent enhancement of Marburg virus infection

Eri Nakayama1, Daisuke Tomabechi, Keita Matsuno

  • 1Department of Global Epidemiology, Hokkaido University Research Center for Zoonosis Control, Sapporo, Japan.

Abstract

Insights

Antibody-dependent enhancement (ADE) can increase Marburg virus (MARV) infectivity. Specific epitopes on MARV glycoprotein (GP) drive this ADE, potentially linking to MARV pathogenicity.

Area of Science:

  • Virology
  • Immunology

Background:

  • Marburg virus (MARV) and Ebola virus (EBOV) are filoviruses causing severe hemorrhagic fever in primates.
  • Antibodies targeting specific glycoprotein (GP) epitopes on EBOV can enhance viral infectivity (antibody-dependent enhancement - ADE).

Purpose of the Study:

  • To investigate antibody-dependent enhancement (ADE) in Marburg virus (MARV) infection.
  • To identify specific epitopes on MARV GP responsible for ADE.

Main Methods:

  • Produced mouse antisera and monoclonal antibodies (mAbs) against MARV strains Angola and Musoke GPs.
  • Assessed ADE activity using pseudotyped vesicular stomatitis virus (VSV) in K562 cells.
  • Mapped ADE epitopes on MARV GP using mAbs.

Main Results:

  • MARV Angola GP antisera significantly enhanced pseudotyped virus infectivity, while Musoke GP antisera showed minimal ADE.
  • Identified three distinct ADE epitopes within the mucin-like region of Angola GP.
  • ADE activity was linked to specific epitopes and glycine at amino acid position 547 in Angola GP, absent in Musoke GP.

Conclusions:

  • Findings suggest a link between ADE and MARV pathogenicity.
  • Provides novel insights into the mechanisms of ADE entry for filoviruses.